Data analysis, clinical biostatistics and more.
Company founded in
Percent employees with university degree
Our team members are experts in biostatistics. Beyond that, we are experienced in project work, working on different infrastructures and with complex processes.
Staburo Client Segments
- Biotech, Medical Device companies, etc.
Temporally and spatially flexible
Experienced in pharma processes
Check out our latest news!
Staburo @ conference of the GMDS & CEN-IBS 2020 Dr. Hannes Buchner, Managing Director from Staburo participated in this online Conference on 08 SEP 2020 and talked about the topic “Children and Career” together with Benjamin Hofner from PEI, Cornelia Kunz and...
Staburo supports research on the impact of coronavirus disease on methodological aspects of ongoing clinical trials
Staburo supports research on the impact of coronavirus disease on methodological aspects of ongoing clinical trials On behalf of Staburo, Josef Höfler and our former colleague Nicole Krämer submitted comments on the EMA’s draft guidance on “Points to consider on...
Post event: Anything new for oncology? Lately, Basel Biometric Section and EFSPI organized a webinar "Estimands addendum is final: Anything new for oncology?". You can find the program, the slides, a recording of the entire event, and a document that answers questions...